Skip to content
  • Sunday, 26 July 2026
  • 2:57 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • UK Approves Lower Dose of Needle-Free Adrenaline Nasal Spray for Young Children
Pharmaceutical R&D

UK Approves Lower Dose of Needle-Free Adrenaline Nasal Spray for Young Children

Teuku Ryan Jun 15, 2026 0

The United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for a new, lower dose of ALK-Abelló’s…

Read More
Neuroscience & Brain Research

Texas A&M University Researchers Develop Breakthrough Nasal Spray to Reverse Brain Aging and Combat Neurodegenerative Decline

Rifan Muazin Jun 3, 2026 0

In a significant advancement for regenerative medicine and neurology, a research team at Texas A&M University has unveiled a novel…

Read More
Neuroscience & Brain Research

Texas A&M Researchers Develop Breakthrough Nasal Spray to Reverse Brain Aging and Combat Cognitive Decline

Rifan Muazin May 27, 2026 0

In a significant advancement for regenerative medicine, a team of scientists at Texas A&M University has developed an experimental nasal…

Read More
Biotech & Genetic Research

Groundbreaking Nasal Spray Delivers Therapeutic miRNA to Combat Neuroinflammaging and Age-Related Cognitive Decline

Jia Lissa Apr 21, 2026 0

Researchers at the Texas A&M University Naresh K. Vashisht College of Medicine (TX, USA), under the leadership of Ashok Shetty,…

Read More
UC San Diego Researchers Unveil High-Efficiency Piezoelectric Hybrid Power Converters to Address Escalating Energy Demands in Modern Data CentersSnail-Inspired Soft Robots Poised to Revolutionize Precision Drug Delivery for Cancer and BeyondPolars Emerges as a High-Performance Challenger to Pandas in Python Data ProcessingTWiV 1284: Clinical Update with Dr. Daniel Griffin
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ